SCHEMBL19414293

SCHEMBL19414293

CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
SRC P12931 7/20 0.46
ABL1 P00519 5/20 0.46
HCK P08631 3/20 0.46
EGFR P00533 3/20 0.46
PIK3CD O00329 3/20 0.46
PIK3CA P42336 3/20 0.46
PIK3CB P42338 3/20 0.46
PIK3CG P48736 3/20 0.46
PRKDC P78527 3/20 0.46
KDR P35968 2/20 0.46
MTOR P42345 2/20 0.46
EPHB4 P54760 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
PI4KB Q9UBF8 1/20 0.44
LCK P06239 1/20 0.43
EPHA3 P29320 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20093454 0.89 SRC (0.61) SRCABL1HCKEGFRPIK3CD
SCHEMBL149528 0.86 KDR (0.52) ALDH1A1MEN1KMT2ASRCABL1
SCHEMBL19414398 0.84 MAP4K4 (0.54) MAPTSRCABL1HCKEGFR
SCHEMBL18235468 0.82 KDR (0.49) ALDH1A1MEN1KMT2ASRCABL1
SCHEMBL12713498 0.82 PIK3CD (0.50) ALDH1A1MAPTMEN1KMT2ASRC
SCHEMBL20093561 0.82 BTK (0.47) ALDH1A1MAPTSRCABL1HCK
SCHEMBL20793881 0.82 PIK3CD (0.60) MAPTSRCABL1HCKEGFR
SCHEMBL3782102 0.81 PIK3CD (0.57) ALDH1A1MEN1KMT2ASRCABL1
SCHEMBL200349 0.81 NUDT14 (0.62) ALDH1A1MAPTMEN1KMT2ASRC
SCHEMBL30387175 0.81 PIK3CD (0.55) SRCABL1HCKEGFRPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858907-B2 Kinase modulators RHIZEN PHARMACEUTICALS AG (CH) 2024-01-02 US disclosed
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-10-15 US disclosed
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10442783-B2 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases PIK3CB, PIK3CD, PDPK1 ALDH1A1 4410/4885MAPT 2596/4885MEN1 3690/4885
US-11858907-B2 Kinase modulators RPS6KA1, RPS6KA2, PRKAR2A ALDH1A1 3748/4885MAPT 3674/4885MEN1 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.